Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.

Exact Sciences Corporation

Status: Completed

Conditions: Colo-rectal Cancer

Treatments: Other: Blood Sample Collection

Study type: Observational

Funder types: Industry

Identifiers

NCT03741166

2018-10B

Details and patient eligibility

About

The primary objective of this sub-study, 2018-10B, is to collect blood specimens to assess new biomarkers for the detection of Colorectal Cancer (CRC).

Full description

Subjects who consent to enroll in Exact Sciences Protocol 2018-10, will be asked to participate in this sub-study. Subjects enrolled in the Exact Sciences Protocol 2018-10, who provide written informed consent to participate in this sub-study, will have a blood sample collected at enrollment.

Enrollment: 871 patients

Sex: All

Ages: 45 to 49 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Subject is currently enrolled in Exact Sciences Protocol 2018-10
2. Subject is willing and able to provide a blood sample.
3. Subject is willing and able to sign informed consent.

Exclusion criteria

1. Subject has any condition that in the opinion of the Investigator should preclude participation in the study.

Trial design

871 participants in 1 patient group

Subject aged 45-49 with Average CRC Risk

Description:

Subjects will be men and women, 45-49 years of age, who enroll in Exact Sciences Protocol 2018-10. Subjects will provide a blood sample at time of enrollment.

Treatment:

Other: Blood Sample Collection